Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: ALPPS versus two-stage hepatectomy for colorectal liver metastases—–a comparative retrospective cohort study

Fig. 1

Overall and recurrence-free survival after ALPPS and TSH/PVE. a Overall survival. The median OS after ALPPS and TSH/PVE was 2.3 years (95% CI 1.6–3.1) and 2.8 years (95% CI 2.1–3.6), respectively. b Recurrence-free survival. The median RFS after ALPPS and TSH/PVE was 1.6 years (95% CI 0.7–2.5) and 0.8 years (95% CI 0.5–1.2), respectively. CI, confidence interval; OS, overall survival; RFS, recurrence-free survival

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us